Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $47.96 and last traded at $47.76, with a volume of 26618 shares. The stock had previously closed at $46.85.
Wall Street Analysts Forecast Growth
Separately, BNP Paribas lowered Sandoz Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, December 2nd.
Check Out Our Latest Research Report on Sandoz Group
Sandoz Group Trading Down 2.8 %
The company's fifty day simple moving average is $43.42 and its 200-day simple moving average is $43.02.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.